A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

NCT06239116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypothalamic Obesity
Prader-Willi Syndrome
PWS

Interventions

DRUG: Part A: RM-718 or placebo (matched to specific RM-718 dose cohort)
DRUG: Part B: RM-718 or placebo (matched to specific RM-718 dose cohort)
DRUG: Part C: RM-718
DRUG: Part D: RM-718

Sponsor

Rhythm Pharmaceuticals, Inc.